
Sign up to save your podcasts
Or


In part two of this two-part series, Dr. Dan Ackerman and Dr. Trey Bateman discuss handling patient requests for blood-based biomarkers for Alzheimer disease and interpreting test results.
By American Academy of Neurology4.8
132132 ratings
In part two of this two-part series, Dr. Dan Ackerman and Dr. Trey Bateman discuss handling patient requests for blood-based biomarkers for Alzheimer disease and interpreting test results.

317 Listeners

496 Listeners

296 Listeners

50 Listeners

295 Listeners

3,339 Listeners

12 Listeners

1,151 Listeners

23 Listeners

194 Listeners

92 Listeners

512 Listeners

366 Listeners

190 Listeners

81 Listeners